Clinical Trial Update: IVUS Guidance to Reduce Contrast in Coronary Angioplasty [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravascular ultrasound guidance to reduce contrast use during coronary angioplasty and its impact on contrast-related adverse events;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Coronary Artery Disease
• Kidney Injury

Snippet

Sponsor: InCor Heart Institute | Conditions: Contrast Media Reaction, Acute Renal Failure | Phase 4 | Status: COMPLETED | Results posted: 2016-06-15